Incidence and Risk of Alzheimers Disease in Individuals with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Nguyen, T. T. H.; Auta, A.; David, E. A.; Ossai, C. I.; Olutuase, V.; Banerjee, M.; Zhao, Y.; Adeloye, D.; Pereira, G.; Adewuyi, E. O.
Show abstract
Background: Epidemiological evidence links type 2 diabetes (T2D) to an increased risk of dementia, including Alzheimers disease (AD). However, previous syntheses often combined heterogeneous diabetes and dementia definitions and have not comprehensively quantified AD incidence among individuals with T2D. We aimed to estimate both the incidence of AD among individuals with T2D and the association between T2D and AD using studies with well-defined T2D and AD outcomes. Methods: We systematically searched MEDLINE, CINAHL (via EBSCO), Embase (via Ovid), and Scopus from inception to April 2026 for studies investigating the incidence of AD among individuals with T2D or the association between T2D and AD. Data were pooled using random-effects models and presented as incidence rates and adjusted relative risks (RRs) with 95% confidence intervals (CIs). Results Of the 9,430 articles identified, 40 studies involving 27,102,559 participants were included. Twenty-three studies contributed incidence data, and 26 reported adjusted relative risks (aRR). The pooled incidence of AD among individuals with T2D was 4.71 per 1,000 person-years (95% CI 3.31, 6.71). T2D was associated with an increased risk of AD (aRR 1.53, 95% CI 1.38, 1.70). Subgroup findings were generally consistent, results were robust in sensitivity analyses, and no publication bias was detected. Conclusions: This study provides a comprehensive quantification of the AD burden associated with T2D by focusing on well-defined AD and T2D outcomes and advancing the field beyond prior broad dementia syntheses. Integrating incidence and relative risk estimates clarifies both the absolute and relative burden of AD in T2D and extends previous syntheses that primarily emphasised relative risk. Individuals with T2D experienced approximately five AD cases per 1,000 person-years and a 53% higher risk of AD, supporting the rationale for integrating cognitive risk prevention into diabetes care.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The tryptophan catabolite or kynurenine pathway in Alzheimer’s disease: a systematic review and meta-analysis 93%
- Blood Biomarkers for Diagnosis & Differential Diagnosis of Alzheimers Disease in Real-World Clinical Populations: A Systematic Review 92%
- Frequency of Variants in Mendelian Alzheimer’s Disease Genes within the Alzheimer’s Disease Sequencing Project (ADSP) 92%
Similar papers in this journal
- Development and Characterization of Proteomic Aging Clocks in the Atherosclerosis Risk in Communities (ARIC) Study 87%
- Factors associated with excess all-cause mortality in the first wave of COVID-19 pandemic in the UK: a time-series analysis using the Clinical Practice Research Datalink 87%
- Sociodemographic Characteristics and Longitudinal Progression of Multimorbidity: A Multistate Modelling Analysis of a Large Primary Care Records Dataset in England 87%
Similar papers in this journal
- Risk models based on non-cognitive measures may identify presymptomatic Alzheimer’s disease 94%
- Impact of different diagnostic measures on drug class association with dementia progression risk: a longitudinal prospective cohort study 93%
- Liver-specific polygenic risk score is more strongly associated than genome-wide score with Alzheimer’s disease diagnosis in a case-control analysis 93%
Similar papers in this journal
- Predictive value of circulating NMR metabolic biomarkers for type 2 diabetes risk in the UK Biobank study 88%
- Maternal smoking during pregnancy and type 1 diabetes in the offspring: A nationwide register-based study with family-based designs 87%
- COVID-19: a retrospective cohort study with focus on the over-80s and hospital-onset disease 87%